112 related articles for article (PubMed ID: 34893107)
1. [Expression of LncRNA-MALAT1 in Peripheral Blood of Patients with Acute Myeloid Leukemia Sepsis and Its Clinical Significance].
Zeng SY; Lyu M; Yuan J; Hu YC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Dec; 29(6):1763-1767. PubMed ID: 34893107
[TBL] [Abstract][Full Text] [Related]
2. Potential role of circulating long noncoding RNA MALAT1 in predicting disease risk, severity, and patients' survival in sepsis.
Geng F; Liu W; Yu L
J Clin Lab Anal; 2019 Oct; 33(8):e22968. PubMed ID: 31301104
[TBL] [Abstract][Full Text] [Related]
3. [Expression and Clinical Significance of LncRNA KCNQ1OT1 in Patients with Acute Myeloid Leukemia].
Jia ZW; Li Y; Cui GR; Zhao HB; Li PY; Luo JM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):653-657. PubMed ID: 29950199
[TBL] [Abstract][Full Text] [Related]
4. [Effect of long non-coding RNA MBNL1-AS1 expression on prognosis of acute myeloid leukemia patients].
Xie W; Qian TT; Pang Y; Ye X; Huang WH; Zhu P; Fu L
Zhonghua Yi Xue Za Zhi; 2021 Apr; 101(13):934-938. PubMed ID: 33789374
[No Abstract] [Full Text] [Related]
5. Expression and Diagnostic Value of lncRNA BLACAT1 in Peripheral Blood of Patients with Acute Myeloid Leukemia.
Wu X; Wang J; Li D; Xu Z
Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255290
[TBL] [Abstract][Full Text] [Related]
6. [Expression and Clinical Significance of LcnRNA XLOC_109948 in Patients with Acute Myeloid Leukemia].
Zhou JY; Wang YM; Peng QY; Hui HL; Yin Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1539-1544. PubMed ID: 33067951
[TBL] [Abstract][Full Text] [Related]
7. Long non‑coding RNA ANRIL is a potential indicator of disease progression and poor prognosis in acute myeloid leukemia.
Tan Z; Zhu K; Yin Y; Luo Z
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300059
[TBL] [Abstract][Full Text] [Related]
8. High expression of lnc-CRNDE presents as a biomarker for acute myeloid leukemia and promotes the malignant progression in acute myeloid leukemia cell line U937.
Wang Y; Zhou Q; Ma JJ
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):763-770. PubMed ID: 29461608
[TBL] [Abstract][Full Text] [Related]
9. Circulating Expression Level of LncRNA Malat1 in Diabetic Kidney Disease Patients and Its Clinical Significance.
Zhou LJ; Yang DW; Ou LN; Guo XR; Wu BL
J Diabetes Res; 2020; 2020():4729019. PubMed ID: 32832561
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA taurine-upregulated gene 1 correlates with unfavorable prognosis in patients with refractory or relapsed acute myeloid leukemia treated by purine analogue based chemotherapy regimens.
Luo W; Yu H; Zou X; Ni X; Wei J
Cancer Biomark; 2018; 23(4):485-494. PubMed ID: 30347595
[TBL] [Abstract][Full Text] [Related]
11. The expression of lncRNA-MALAT1 in breast cancer patients and its influences on prognosis.
Sun Z; Liu J; Liu J
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):72-78. PubMed ID: 32538750
[TBL] [Abstract][Full Text] [Related]
12. Identification of the 7-lncRNA Signature as a Prognostic Biomarker for Acute Myeloid Leukemia.
Liu CY; Guo HH; Li HX; Liang Y; Tang C; Chen NN
Dis Markers; 2021; 2021():8223216. PubMed ID: 34966465
[TBL] [Abstract][Full Text] [Related]
13. Identification of long non-coding RNA MVIH as a prognostic marker and therapeutic target in acute myeloid leukemia.
Jiang Z; Yu Q; Luo X
J Clin Lab Anal; 2020 Apr; 34(4):e23113. PubMed ID: 31724217
[TBL] [Abstract][Full Text] [Related]
14. Correlation of long non-coding RNA taurine-upregulated gene 1 with disease conditions and prognosis, as well as its effect on cell activities in acute myeloid leukemia.
Qin J; Bao H; Li H
Cancer Biomark; 2018; 23(4):569-577. PubMed ID: 30452403
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA taurine-upregulated gene 1 correlates with poor prognosis, induces cell proliferation, and represses cell apoptosis via targeting aurora kinase A in adult acute myeloid leukemia.
Wang X; Zhang L; Zhao F; Xu R; Jiang J; Zhang C; Liu H; Huang H
Ann Hematol; 2018 Aug; 97(8):1375-1389. PubMed ID: 29654398
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA MALAT1 modulate cell migration, proliferation and apoptosis by sponging microRNA-146a to regulate CXCR4 expression in acute myeloid leukemia.
Sheng XF; Hong LL; Li H; Huang FY; Wen Q; Zhuang HF
Hematology; 2021 Dec; 26(1):43-52. PubMed ID: 33382018
[TBL] [Abstract][Full Text] [Related]
17. The implication of lncRNA expression pattern and potential function of lncRNA RP4-576H24.2 in acute myeloid leukemia.
Zheng J; Song Y; Li Z; Tang A; Fei Y; He W
Cancer Med; 2019 Dec; 8(17):7143-7160. PubMed ID: 31568697
[TBL] [Abstract][Full Text] [Related]
18. MALAT1 knockdown inhibits proliferation and enhances cytarabine chemosensitivity by upregulating miR-96 in acute myeloid leukemia cells.
Hu N; Chen L; Wang C; Zhao H
Biomed Pharmacother; 2019 Apr; 112():108720. PubMed ID: 30970520
[TBL] [Abstract][Full Text] [Related]
19. The clinical value of lncRNA MALAT1 and its targets miR-125b, miR-133, miR-146a, and miR-203 for predicting disease progression in chronic obstructive pulmonary disease patients.
Liu S; Liu M; Dong L
J Clin Lab Anal; 2020 Sep; 34(9):e23410. PubMed ID: 32583510
[TBL] [Abstract][Full Text] [Related]
20. Expression and prognostic relevance of long noncoding RNAs CRNDE and AOX2P in adult acute myeloid leukemia.
Hola MAM; Ali MAM; ElNahass Y; Salem TAE; Mohamed MR
Int J Lab Hematol; 2021 Aug; 43(4):732-742. PubMed ID: 34129278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
